Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts
- PMID: 26572796
- PMCID: PMC4679527
- DOI: 10.1161/CIRCULATIONAHA.115.017341
Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts
Abstract
Background: The association between consumption of caffeinated and decaffeinated coffee and risk of mortality remains inconclusive.
Methods and results: We examined the associations of consumption of total, caffeinated, and decaffeinated coffee with risk of subsequent total and cause-specific mortality among 74,890 women in the Nurses' Health Study (NHS), 93,054 women in the Nurses' Health Study II, and 40,557 men in the Health Professionals Follow-up Study. Coffee consumption was assessed at baseline using a semiquantitative food frequency questionnaire. During 4,690,072 person-years of follow-up, 19,524 women and 12,432 men died. Consumption of total, caffeinated, and decaffeinated coffee were nonlinearly associated with mortality. Compared with nondrinkers, coffee consumption of 1 to 5 cups per day was associated with lower risk of mortality, whereas coffee consumption of more than 5 cups per day was not associated with risk of mortality. However, when restricting to never smokers compared with nondrinkers, the hazard ratios (and 95% confidence intervals) of mortality were 0.94 (0.89-0.99) for 1.0 or less cup per day, 0.92 (0.87-0.97) for 1.1 to 3.0 cups per day, 0.85 (0.79-0.92) for 3.1 to 5.0 cup per day, and 0.88 (0.78-0.99) for more than 5.0 cup per day (P value for nonlinearity = 0.32; P value for trend < 0.001). Significant inverse associations were observed for caffeinated (P value for trend < 0.001) and decaffeinated coffee (P value for trend = 0.022). Significant inverse associations were observed between coffee consumption and deaths attributed to cardiovascular disease, neurologic diseases, and suicide. No significant association between coffee consumption and total cancer mortality was found.
Conclusions: Higher consumption of total coffee, caffeinated coffee, and decaffeinated coffee was associated with lower risk of total mortality.
Keywords: coffee; mortality; smoking.
© 2015 American Heart Association, Inc.
Figures


Comment in
-
Risk factors: Moderate coffee drinking is associated with lower risk of death from CVD.Nat Rev Cardiol. 2016 Feb;13(2):64. doi: 10.1038/nrcardio.2015.189. Epub 2015 Dec 3. Nat Rev Cardiol. 2016. PMID: 26631847 No abstract available.
-
Higher coffee consumption is associated with lower risk of all-cause and cause-specific mortality in three large prospective cohorts.Evid Based Med. 2016 Jun;21(3):108. doi: 10.1136/ebmed-2016-110399. Epub 2016 Mar 3. Evid Based Med. 2016. PMID: 26940712 No abstract available.
-
Mindfulness-Based Stress Reduction for Posttraumatic Stress Disorder, Coffee Consumption and Mortality, Phytoestrogens for Menopause, Light Therapy for Non-Seasonal Depression, Electroacupuncture for Labor Pain.Explore (NY). 2016 May-Jun;12(3):210-4. doi: 10.1016/j.explore.2016.02.013. Epub 2016 Mar 2. Explore (NY). 2016. PMID: 27061036 No abstract available.
-
Letter by Aubin et al Regarding Article, "Association of Coffee Consumption with Total and Cause-Specific Mortality in 3 Large Prospective Cohorts".Circulation. 2016 May 17;133(20):e659. doi: 10.1161/CIRCULATIONAHA.115.020594. Circulation. 2016. PMID: 27185028 No abstract available.
-
Response to Letter Regarding Article, "Association of Coffee Consumption With Total and Cause-Specific Mortality in 3 Large Prospective Cohorts".Circulation. 2016 May 17;133(20):e660. doi: 10.1161/CIRCULATIONAHA.116.022322. Circulation. 2016. PMID: 27185029 Free PMC article. No abstract available.
References
-
- Je Y, Giovannucci E. Coffee consumption and risk of endometrial cancer: Findings from a large up-to-date meta-analysis. Int J Cancer. 2012;131:1700–1710. - PubMed
-
- Song F, Qureshi AA, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res. 2012;72:3282–3289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 CA087969/CA/NCI NIH HHS/United States
- UM1 CA176726/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- HL60712/HL/NHLBI NIH HHS/United States
- HL088521/HL/NHLBI NIH HHS/United States
- UL1 TR001108/TR/NCATS NIH HHS/United States
- P01 CA87969/CA/NCI NIH HHS/United States
- R01 HL034594/HL/NHLBI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- HL35464/HL/NHLBI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- R01 HL035464/HL/NHLBI NIH HHS/United States
- R01 HL088521/HL/NHLBI NIH HHS/United States
- R01 HL060712/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical